Last update 09 Jun 2025

Tumor Infiltrating Lymphocyte Therapy(Johns Hopkins All Children's Hospital)

Overview

Basic Info

Drug Type
TIL therapy
Synonyms-
Target-
Action-
Mechanism
Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsCongenital DisordersUrogenital Diseases+ [1]
Active Indication
Childhood Malignant Solid NeoplasmMetastatic Soft Tissue SarcomaWilms Tumor
Inactive Indication-
Originator Organization
Johns Hopkins All Children's HospitalJohns Hopkins All Children's Hospital
Active Organization
H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Tumor Infiltrating Lymphocyte Therapy(Johns Hopkins All Children's Hospital)
NCT06047977
/ RecruitingPhase 1IIT
Tumor Infiltrating Lymphocytes in Pediatric Malignant Solid Tumors: A Prospective Biobanking Study and Phase I Clinical Trial
100 Clinical Results associated with Tumor Infiltrating Lymphocyte Therapy(Johns Hopkins All Children's Hospital)
Login to view more data
100 Translational Medicine associated with Tumor Infiltrating Lymphocyte Therapy(Johns Hopkins All Children's Hospital)
Login to view more data
100 Patents (Medical) associated with Tumor Infiltrating Lymphocyte Therapy(Johns Hopkins All Children's Hospital)
Login to view more data
100 Deals associated with Tumor Infiltrating Lymphocyte Therapy(Johns Hopkins All Children's Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Childhood Malignant Solid NeoplasmPhase 1
United States
H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
02 Jun 2025
Metastatic Soft Tissue SarcomaPhase 1
United States
H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
02 Jun 2025
Wilms TumorPhase 1
United States
H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
02 Jun 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free